Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Justin P. Reinert & Rebecca L. Dunn. (2019) Management of overdoses of loperamide, gabapentin, and modafinil: a literature review. Expert Review of Clinical Pharmacology 12:9, pages 901-908.
Read now
Read now
Nataša Dragašević-Mišković, Igor Petrović, Iva Stanković & Vladimir S. Kostić. (2019) Chemical management of levodopa-induced dyskinesia in Parkinson’s disease patients. Expert Opinion on Pharmacotherapy 20:2, pages 219-230.
Read now
Read now
Yifan Gao, Xiaoling Wu, Zhongxing Wang, Pengjie Luo, Liguang Xu, Qiankun Zheng & Hua Kuang. (2019) A sensitive lateral flow immunoassay for the multiple residues of five adamantanes. Food and Agricultural Immunology 30:1, pages 647-661.
Read now
Read now
Pinky Agarwal, Sudeshna Ray, Daniel Burdick, Alida F Griffith & Arina Madan. (2018) Efficacy and safety of ADS-5102 (amantadine) extended-release capsules for treating levodopa-induced dyskinesia. Expert Opinion on Orphan Drugs 6:10, pages 625-634.
Read now
Read now
Articles from other publishers (20)
M. T. Herrero, J. E. Yuste, L. Cuenca-Bermejo, P. Almela, L. Arenas-Betancur, V. De Pablos, A. Gonzalez-Cuello, E. Del Bel, J. Navarro-Zaragoza & E. Fernández-Villalba. (2023) 7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate. Open Biology 13:5.
Crossref
Crossref
Destany K. Kwon, Mohit Kwatra, Jing Wang & Han Seok Ko. (2022) Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies. Cells 11:23, pages 3736.
Crossref
Crossref
Komal Latif, Aman Ullah, Anastasiia D. Shkodina, Dmytro I. Boiko, Zakia Rafique, Badrah S. Alghamdi, Mohamed A. Alfaleh & Ghulam Md. Ashraf. (2022) Drug reprofiling history and potential therapies against Parkinson’s disease. Frontiers in Pharmacology 13.
Crossref
Crossref
Tomasz Karabin, Grazyna Biala & Marta Kruk-Slomka. (2022) The recent guidelines for pharmacotherapy of Parkinson’s Disease. Current Issues in Pharmacy and Medical Sciences 35:2, pages 80-85.
Crossref
Crossref
Wiesner AgnieszkaPaśko PawełKujawska Małgorzata. (2022) How to Optimize the Effectiveness and Safety of Parkinson’s Disease
Therapy? – A Systematic Review of Drugs Interactions with Food and Dietary
Supplements. Current Neuropharmacology 20:7, pages 1427-1447.
Crossref
Crossref
Sophie R. Cohen, Michelle L. Terry, Michael Coyle, Emily Wheelis, Ashley Centner, Samantha Smith, John Glinski, Natalie Lipari, Carla Budrow, Fredric P. Manfredsson & Christopher Bishop. (2022) The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats. Pharmacology Biochemistry and Behavior 217, pages 173393.
Crossref
Crossref
Yi Hua, Xiaowen Dai, Yuan Xu, Guomeng Xing, Haichun Liu, Tao Lu, Yadong Chen & Yanmin Zhang. (2022) Drug repositioning: Progress and challenges in drug discovery for various diseases. European Journal of Medicinal Chemistry 234, pages 114239.
Crossref
Crossref
Rajesh Pahwa. (2021) Amantadine: an old drug reborn. The Lancet Neurology 20:12, pages 975-977.
Crossref
Crossref
Jikke T Boelens Keun, Ilse Ac Arnoldussen, Chris Vriend & Ondine van de Rest. (2021) Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review. Advances in Nutrition 12:6, pages 2265-2287.
Crossref
Crossref
Sarah Marmol, Matthew Feldman, Carlos Singer & Jason Margolesky. (2021) Amantadine Revisited: A Contender for Initial Treatment in Parkinson’s Disease?. CNS Drugs 35:11, pages 1141-1152.
Crossref
Crossref
Takeshi Enomoto, Tomokazu Nakako, Masao Goda, Erika Wada, Atsushi Kitamura, Yuki Fujii & Kazuhito Ikeda. (2021) A novel phosphodiesterase 1 inhibitor reverses L-dopa-induced dyskinesia, but not motivation deficits, in monkeys. Pharmacology Biochemistry and Behavior 205, pages 173183.
Crossref
Crossref
Shruti Sharma, Shalini Trivedi, Taruna Pandey, Sachin Ranjan, Mashu Trivedi & Rakesh Pandey. (2020) Wedelolactone Mitigates Parkinsonism Via Alleviating Oxidative Stress and Mitochondrial Dysfunction Through NRF2/SKN-1. Molecular Neurobiology 58:1, pages 65-77.
Crossref
Crossref
Susanna Waters, Clas Sonesson, Peder Svensson, Joakim Tedroff, Manolo Carta, Elisabeth Ljung, Jenny Gunnergren, Malin Edling, Boel Svanberg, Anne Fagerberg, Johan Kullingsjö, Stephan Hjorth & Nicholas Waters. (2020) Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease. Journal of Pharmacology and Experimental Therapeutics 374:1, pages 113-125.
Crossref
Crossref
Peggy Rentsch, Sandy Stayte, Timothy Egan, Ian Clark & Bryce Vissel. (2020) Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia. Neurobiology of Disease 134, pages 104646.
Crossref
Crossref
William Roberts, Craig Beavers, Samuel Jellison & Matt Vassar. (2020) Completeness of intervention reporting in neurology randomized controlled trials: a retrospective, cross-sectional study. International Journal of Evidence-Based Healthcare 18:2, pages 212-221.
Crossref
Crossref
Khalid Orayj & Emma Lane. (2019) Patterns and Determinants of Prescribing for Parkinson’s Disease: A Systematic Literature Review. Parkinson's Disease 2019, pages 1-40.
Crossref
Crossref
Imane Frouni, Adjia Hamadjida, Cynthia Kwan, Dominique Bédard, Vaidehi Nafade, Fleur Gaudette, Stephen G. Nuara, Jim C. Gourdon, Francis Beaudry & Philippe Huot. (2019) Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism. Neuropharmacology 158, pages 107725.
Crossref
Crossref
Harsh V. Gupta, Kelly E. Lyons & Rajesh Pahwa. (2019) Old Drugs, New Delivery Systems in Parkinson’s Disease. Drugs & Aging 36:9, pages 807-821.
Crossref
Crossref
Mingfei Pan, Jingying Yang, Shijie Li, Guozhu Wang, Junping Wang & Shuo Wang. (2019) Indirect competitive ELISA and colloidal gold-based immunochromatographic strip for amantadine detection in animal-derived foods. Analytical Methods 11:15, pages 2027-2032.
Crossref
Crossref
Eva Zusinaite, Aleksandr Ianevski, Diana Niukkanen, Minna Poranen, Magnar Bjørås, Jan Afset, Tanel Tenson, Vidya Velagapudi, Andres Merits & Denis Kainov. (2018) A Systems Approach to Study Immuno- and Neuro-Modulatory Properties of Antiviral Agents. Viruses 10:8, pages 423.
Crossref
Crossref